GX-051
/ Genexine
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 23, 2025
Genetically Modified Mesenchymal Stem Cell Theraopeutic Against Head and Neck Cancer
(clinicaltrials.gov)
- P1 | N=12 | Completed | Sponsor: Genexine, Inc. | Unknown status ➔ Completed
Trial completion • Gene Therapies • Head and Neck Cancer • Oncology • Solid Tumor • IL12A
1 to 1
Of
1
Go to page
1